GLAND PHARMA
|
GLAND PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹1,465 Cr | ₹1,063 Cr | ₹1,133 Cr | ₹1,055 Cr | ₹1,619 Cr |
| Adjustment | ₹277 Cr | ₹212 Cr | ₹224 Cr | ₹38 Cr | ₹-28 Cr |
| Changes In working Capital | ₹-254 Cr | ₹-6.06 Cr | ₹-53 Cr | ₹-418 Cr | ₹-393 Cr |
| Cash Flow after changes in Working Capital | ₹1,487 Cr | ₹1,269 Cr | ₹1,303 Cr | ₹675 Cr | ₹1,197 Cr |
| Cash Flow from Operating Activities | ₹1,031 Cr | ₹915 Cr | ₹997 Cr | ₹364 Cr | ₹791 Cr |
| Cash Flow from Investing Activities | ₹138 Cr | ₹1,705 Cr | ₹-1,757 Cr | ₹1,208 Cr | ₹-1,003 Cr |
| Cash Flow from Financing Activities | ₹-417 Cr | ₹-433 Cr | ₹-799 Cr | ₹15 Cr | ₹35 Cr |
| Net Cash Inflow / Outflow | ₹752 Cr | ₹2,186 Cr | ₹-1,560 Cr | ₹1,587 Cr | ₹-177 Cr |
| Opening Cash & Cash Equivalents | ₹2,556 Cr | ₹357 Cr | ₹1,909 Cr | ₹319 Cr | ₹492 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹51 Cr | ₹13 Cr | ₹7.72 Cr | ₹3.00 Cr | ₹3.31 Cr |
| Closing Cash & Cash Equivalent | ₹3,359 Cr | ₹2,556 Cr | ₹357 Cr | ₹1,909 Cr | ₹319 Cr |
Compare Cashflow Statement of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹47,988.6 Cr | -0.5% | 18.7% | 53.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -0.5% |
18.7% |
53.6% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses